View Past PerformanceÖsterreichische Post バランスシートの健全性財務の健全性 基準チェック /26Österreichische Postの総株主資本は€761.6M 、総負債は€745.3Mで、負債比率は97.9%となります。総資産と総負債はそれぞれ€6.5Bと€5.7Bです。 Österreichische Postの EBIT は€168.8Mで、利息カバレッジ比率22.5です。現金および短期投資は€118.9Mです。主要情報97.86%負債資本比率€745.30m負債インタレスト・カバレッジ・レシオ22.5x現金€118.90mエクイティ€761.60m負債合計€5.73b総資産€6.49b財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Mar 13Österreichische Post AG announces Annual dividend, payable on April 29, 2026Österreichische Post AG announced Annual dividend of EUR 1.8300 per share payable on April 29, 2026, ex-date on April 24, 2026 and record date on April 27, 2026.お知らせ • Jan 28The Platform Group AG (XTRA:TPG0) signed an agreement to acquire AEP GmbH from Österreichische Post AG (WBAG:POST) and a group of shareholders.The Platform Group AG (XTRA:TPG0) signed an agreement to acquire AEP GmbH from Österreichische Post AG (WBAG:POST) and a group of shareholders on January 26, 2026. The acquisition will be financed based on a clearly defined financing concept, combining internal funds, equity and debt capital. By March 2026, the Management Board intends to implement an adjusted and sustainable financing structure in connection with the acquisition of AEP. In this context, the Platform Group has resolved on two capital increases excluding subscription rights, comprising a total of 2 million new shares to be placed with long-term investors, with gross proceeds of €9.8 million. Registration in the commercial register is expected by February 2026. For the period ending December 31, 2025, AEP GmbH reported total revenue of €1 billion. Following the acquisition, The Platform Group intends to establish the pharmaceutical business as a standalone segment. Going forward, this segment will operate under the name Pharma & Service Goods. In addition, the pharmaceutical activities are to be organized as a fully independent business unit with its own dedicated management team. Following closing, The Platform Group intends to bundle its existing pharmaceutical and pharmacy-related activities under the umbrella brand “Pharma Group.” This will include AEP, ApoNow, apothekia, and the Doc.Green platform. The transaction is subject to regulatory approval, German Federal Cartel Office approval and the fulfillment of customary closing conditions. The transaction is expected to close in the first to second quarter of 2026.お知らせ • Dec 09Österreichische Post AG, Annual General Meeting, Apr 15, 2026Österreichische Post AG, Annual General Meeting, Apr 15, 2026.お知らせ • Aug 09+ 3 more updatesÖsterreichische Post AG to Report First Half, 2026 Results on Aug 07, 2026Österreichische Post AG announced that they will report first half, 2026 results on Aug 07, 2026お知らせ • Jan 27Österreichische Post AG, Annual General Meeting, Apr 09, 2025Österreichische Post AG, Annual General Meeting, Apr 09, 2025.お知らせ • Aug 20+ 3 more updatesÖsterreichische Post AG to Report Fiscal Year 2024 Results on Mar 07, 2025Österreichische Post AG announced that they will report fiscal year 2024 results on Mar 07, 2025お知らせ • Dec 19Österreichische Post AG Appoints Walter Oblin as CEO, Effective 1 October 2024At its meeting on 18 December 2023, the Supervisory Board of Austrian Post appointed Walter Oblin as Chairman of the Management Board and CEO of Austrian Post. The appointment takes effect on 1 October 2024. Walter Oblin has been with the company since 1 October 2009 and has been Chief Financial Officer of Austrian Post since 1 July 2012. On 1 January 2019, he was appointed Deputy Chief Executive Officer and, in addition to his role as Management Board Member responsible for Finance, also took on responsibility for the Mail Division. Walter Oblin will continue in his current role as Management Board Member responsible for Finance and Mail (CFO) until he takes over the position of the Chairman of the Management Board.お知らせ • Aug 12+ 4 more updatesÖsterreichische Post AG, Annual General Meeting, Apr 18, 2024Österreichische Post AG, Annual General Meeting, Apr 18, 2024.New Risk • Jun 10New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 56% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Dividend is not well covered by earnings and cash flows. Payout ratio: 94% Paying a dividend despite having no free cash flows. High level of non-cash earnings (56% accrual ratio).財務状況分析短期負債: OERC.Fの 短期資産 ( €3.4B ) は 短期負債 ( €4.9B ) をカバーしていません。長期負債: OERC.Fの短期資産 ( €3.4B ) が 長期負債 ( €858.3M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: OERC.Fの 純負債対資本比率 ( 82.2% ) は 高い と見なされます。負債の削減: OERC.Fの負債対資本比率は、過去 5 年間で5.4%から97.9%に増加しました。債務返済能力: OERC.Fの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 16.3% )。インタレストカバレッジ: OERC.Fの負債に対する 利息支払い は EBIT ( 22.5 x coverage) によって 十分にカバーされています。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YTransportation 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/06/16 21:08終値2025/03/19 00:00収益2025/03/31年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Österreichische Post AG 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16 アナリスト機関Marco LimiteBarclaysWilliam Fitzalan HowardBerenbergOthmane BrichaBofA Global Research13 その他のアナリストを表示
お知らせ • Mar 13Österreichische Post AG announces Annual dividend, payable on April 29, 2026Österreichische Post AG announced Annual dividend of EUR 1.8300 per share payable on April 29, 2026, ex-date on April 24, 2026 and record date on April 27, 2026.
お知らせ • Jan 28The Platform Group AG (XTRA:TPG0) signed an agreement to acquire AEP GmbH from Österreichische Post AG (WBAG:POST) and a group of shareholders.The Platform Group AG (XTRA:TPG0) signed an agreement to acquire AEP GmbH from Österreichische Post AG (WBAG:POST) and a group of shareholders on January 26, 2026. The acquisition will be financed based on a clearly defined financing concept, combining internal funds, equity and debt capital. By March 2026, the Management Board intends to implement an adjusted and sustainable financing structure in connection with the acquisition of AEP. In this context, the Platform Group has resolved on two capital increases excluding subscription rights, comprising a total of 2 million new shares to be placed with long-term investors, with gross proceeds of €9.8 million. Registration in the commercial register is expected by February 2026. For the period ending December 31, 2025, AEP GmbH reported total revenue of €1 billion. Following the acquisition, The Platform Group intends to establish the pharmaceutical business as a standalone segment. Going forward, this segment will operate under the name Pharma & Service Goods. In addition, the pharmaceutical activities are to be organized as a fully independent business unit with its own dedicated management team. Following closing, The Platform Group intends to bundle its existing pharmaceutical and pharmacy-related activities under the umbrella brand “Pharma Group.” This will include AEP, ApoNow, apothekia, and the Doc.Green platform. The transaction is subject to regulatory approval, German Federal Cartel Office approval and the fulfillment of customary closing conditions. The transaction is expected to close in the first to second quarter of 2026.
お知らせ • Dec 09Österreichische Post AG, Annual General Meeting, Apr 15, 2026Österreichische Post AG, Annual General Meeting, Apr 15, 2026.
お知らせ • Aug 09+ 3 more updatesÖsterreichische Post AG to Report First Half, 2026 Results on Aug 07, 2026Österreichische Post AG announced that they will report first half, 2026 results on Aug 07, 2026
お知らせ • Jan 27Österreichische Post AG, Annual General Meeting, Apr 09, 2025Österreichische Post AG, Annual General Meeting, Apr 09, 2025.
お知らせ • Aug 20+ 3 more updatesÖsterreichische Post AG to Report Fiscal Year 2024 Results on Mar 07, 2025Österreichische Post AG announced that they will report fiscal year 2024 results on Mar 07, 2025
お知らせ • Dec 19Österreichische Post AG Appoints Walter Oblin as CEO, Effective 1 October 2024At its meeting on 18 December 2023, the Supervisory Board of Austrian Post appointed Walter Oblin as Chairman of the Management Board and CEO of Austrian Post. The appointment takes effect on 1 October 2024. Walter Oblin has been with the company since 1 October 2009 and has been Chief Financial Officer of Austrian Post since 1 July 2012. On 1 January 2019, he was appointed Deputy Chief Executive Officer and, in addition to his role as Management Board Member responsible for Finance, also took on responsibility for the Mail Division. Walter Oblin will continue in his current role as Management Board Member responsible for Finance and Mail (CFO) until he takes over the position of the Chairman of the Management Board.
お知らせ • Aug 12+ 4 more updatesÖsterreichische Post AG, Annual General Meeting, Apr 18, 2024Österreichische Post AG, Annual General Meeting, Apr 18, 2024.
New Risk • Jun 10New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 56% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Dividend is not well covered by earnings and cash flows. Payout ratio: 94% Paying a dividend despite having no free cash flows. High level of non-cash earnings (56% accrual ratio).